SCHEMBL5149199

SCHEMBL5149199

COc1nc(-c2ccccc2)c(-c2ccc(=O)n(C(C)C)n2)nc1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 2/20 0.50
KDM5A P29375 7/20 0.37
KDM6B O15054 1/20 0.37
KDM5C P41229 1/20 0.37
KDM5D Q9BY66 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
PHF8 Q9UPP1 1/20 0.37
SQOR Q9Y6N5 3/20 0.37
MAT2A P31153 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CHEK1 O14757 1/20 0.34
ABL1 P00519 1/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
FLT1 P17948 1/20 0.34
GRK5 P34947 1/20 0.34
KDR P35968 1/20 0.34
MAP2K2 P36507 1/20 0.34
CDK8 P49336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5152899 0.90 USP8 (0.40) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5147922 0.85 USP8 (0.46) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5147962 0.85 USP8 (0.46) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5150959 0.84 FGFR1 (0.39) ABL1KDRADORA2AADORA1TP53
SCHEMBL5147988 0.81 TP53 (0.39) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL6538925 0.81 AKT1 (0.42) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5149107 0.81 TP53 (0.37) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5147991 0.81 TP53 (0.37) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5149146 0.81 TP53 (0.39) USP8KDM5AKDM6BKDM5CKDM5D
SCHEMBL5149015 0.80 TP53 (0.39) ALDH1A1KDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265120-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2007-09-04 US disclosed
US-20050222159-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222159-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, HTR5A, ADORA1 USP8 4814/4885KDM5A 2066/4885KDM6B 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.